Venus Concept Inc. (NASDAQ:VERO – Get Rating) insider Ross Portaro acquired 60,000 shares of Venus Concept stock in a transaction dated Monday, November 21st. The stock was purchased at an average price of $0.22 per share, with a total value of $13,200.00. Following the completion of the purchase, the insider now directly owns 120,000 shares of the company’s stock, valued at approximately $26,400. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Venus Concept Trading Up 60.0 %
Shares of VERO opened at $0.35 on Thursday. The company has a current ratio of 2.74, a quick ratio of 1.92 and a debt-to-equity ratio of 7.75. Venus Concept Inc. has a one year low of $0.15 and a one year high of $2.21. The company’s fifty day moving average price is $0.33 and its 200 day moving average price is $0.48.
Venus Concept (NASDAQ:VERO – Get Rating) last issued its quarterly earnings results on Thursday, November 10th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.10). Venus Concept had a negative net margin of 35.36% and a negative return on equity of 140.67%. The business had revenue of $21.54 million during the quarter. Equities research analysts anticipate that Venus Concept Inc. will post -0.65 earnings per share for the current year.
Institutional Trading of Venus Concept
Venus Concept Company Profile
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
- Get a free copy of the StockNews.com research report on Venus Concept (VERO)
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Is the 60/40 Portfolio Mix Still in Vogue?
- Microsoft Shares: Is it Time to Back Up the Truck?
- Three CBD Stocks to Dominate a Budding Industry
- Institutional Support for Analog Devices Remains High
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.